Recently, Gaedcke et al. [43] reported a de novo protein expression of EGFR in the brain metastases of matched primary and metastatic breast cancer cases, and mouse models have shown the EGFR ligand HBEGF to be one of the key mediators of cancer-cell passage through the blood-brain barrier [5]. This evidence concerns the gene HBEGF and breast carcinoma.